Corporate & Securities Law Community | LexisNexis
Featured Content

06/21/2010 04:21:00 PM EST

Biovail, Valeant Pharma agree to combine

NEW YORK-(AP) Canadian drugmaker Biovail Corp. and Valeant Pharmaceuticals International said Monday they are forming a new company under the Valeant name, capping Biovail's recovery from falling sales and financial scandals.

Combined, the companies had $1.65 billion in revenue in 2009. They say their size, financial strength and product lines will allow…

Subscribers to www.lexis.com may read the full version of this article here.


 
Similar Content

Securities Law

Corporate Law

Foreign Corrupt Practices Act Law & Compliance

Venture Capital

Dodd-Frank Financial Reform

News

Podcasts

Videocasts & Webinars

Emerging Issues

Free Downloads

LexisNexis Resources

Add a Comment

(required)  
(optional)
(required)  
Enter the Image Code: